Consun Pharma repurchases 27,000 shares for HKD 0.37 million; outstanding share count slips to 840.29 million

Bulletin Express06-11 21:21

Consun Pharmaceutical Group Limited (Consun Pharma) disclosed a small-scale on-market share buyback on 11 June 2026, further utilising its current repurchase mandate.

The company acquired 27,000 ordinary shares on the Hong Kong Stock Exchange at prices ranging from HKD 13.52 to HKD 13.63, translating into a volume-weighted average cost of HKD 13.55 per share and an aggregate outlay of HKD 0.37 million.

Key post-transaction metrics: • Issued shares (excluding treasury shares) declined to 840.29 million, a marginal reduction of 0.0032 %. • Treasury share balance increased to 1.26 million shares. • Total shares in issue (including treasury shares) remained unchanged at 841.55 million.

Mandate utilisation: • Shareholders authorised the board on 26 May 2026 to repurchase up to 84.12 million shares. • Cumulative buybacks under this mandate now total 0.91 million shares, representing 1.08 % of the company’s issued share capital at mandate date. • Approximately 83.21 million shares—98.9 % of the approved limit—remain available for future repurchases.

Pursuant to Hong Kong listing rules, Consun Pharma is restricted from issuing new shares or disposing of treasury shares until 11 July 2026, 30 days after the latest repurchase.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1142391568?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-11 21:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1142391568","market":"hk","top_or_hot":-1,"title":"Consun Pharma repurchases 27,000 shares for HKD 0.37 million; outstanding share count slips to 840.29 million","media":"Bulletin Express","content":"<p>Consun Pharmaceutical Group Limited (Consun Pharma) disclosed a small-scale on-market share buyback on 11 June 2026, further utilising its current repurchase mandate.</p>\n<p>The company acquired 27,000 ordinary shares on the Hong Kong Stock Exchange at prices ranging from HKD 13.52 to HKD 13.63, translating into a volume-weighted average cost of HKD 13.55 per share and an aggregate outlay of HKD 0.37 million.</p>\n<p>Key post-transaction metrics:  \n• Issued shares (excluding treasury shares) declined to 840.29 million, a marginal reduction of 0.0032 %.  \n• Treasury share balance increased to 1.26 million shares.  \n• Total shares in issue (including treasury shares) remained unchanged at 841.55 million.</p>\n<p>Mandate utilisation:  \n• Shareholders authorised the board on 26 May 2026 to repurchase up to 84.12 million shares.  \n• Cumulative buybacks under this mandate now total 0.91 million shares, representing 1.08 % of the company’s issued share capital at mandate date.  \n• Approximately 83.21 million shares—98.9 % of the approved limit—remain available for future repurchases.</p>\n<p>Pursuant to Hong Kong listing rules, Consun Pharma is restricted from issuing new shares or disposing of treasury shares until 11 July 2026, 30 days after the latest repurchase.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Consun Pharma repurchases 27,000 shares for HKD 0.37 million; outstanding share count slips to 840.29 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nConsun Pharma repurchases 27,000 shares for HKD 0.37 million; outstanding share count slips to 840.29 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-11 21:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Consun Pharmaceutical Group Limited (Consun Pharma) disclosed a small-scale on-market share buyback on 11 June 2026, further utilising its current repurchase mandate.</p>\n<p>The company acquired 27,000 ordinary shares on the Hong Kong Stock Exchange at prices ranging from HKD 13.52 to HKD 13.63, translating into a volume-weighted average cost of HKD 13.55 per share and an aggregate outlay of HKD 0.37 million.</p>\n<p>Key post-transaction metrics:  \n• Issued shares (excluding treasury shares) declined to 840.29 million, a marginal reduction of 0.0032 %.  \n• Treasury share balance increased to 1.26 million shares.  \n• Total shares in issue (including treasury shares) remained unchanged at 841.55 million.</p>\n<p>Mandate utilisation:  \n• Shareholders authorised the board on 26 May 2026 to repurchase up to 84.12 million shares.  \n• Cumulative buybacks under this mandate now total 0.91 million shares, representing 1.08 % of the company’s issued share capital at mandate date.  \n• Approximately 83.21 million shares—98.9 % of the approved limit—remain available for future repurchases.</p>\n<p>Pursuant to Hong Kong listing rules, Consun Pharma is restricted from issuing new shares or disposing of treasury shares until 11 July 2026, 30 days after the latest repurchase.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01681","symbol_name":"康臣药业","start_time":0,"source_url":"","article_id":"1142391568","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1142391568","pubTimestamp":1781184088,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Consun Pharmaceutical Group Limited (Consun Pharma) disclosed a small-scale on-market share buyback on 11 June 2026, further utilising its current repurchase mandate. The company acquired 27,000...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01681":"康臣药业"},"translate_title":"康臣药业0.37万港元回购2.7万股；流通股数量下滑至8.4029亿股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01681":1},"content_text":"Consun Pharmaceutical Group Limited (Consun Pharma) disclosed a small-scale on-market share buyback on 11 June 2026, further utilising its current repurchase mandate.\nThe company acquired 27,000 ordinary shares on the Hong Kong Stock Exchange at prices ranging from HKD 13.52 to HKD 13.63, translating into a volume-weighted average cost of HKD 13.55 per share and an aggregate outlay of HKD 0.37 million.\nKey post-transaction metrics:  \n• Issued shares (excluding treasury shares) declined to 840.29 million, a marginal reduction of 0.0032 %.  \n• Treasury share balance increased to 1.26 million shares.  \n• Total shares in issue (including treasury shares) remained unchanged at 841.55 million.\nMandate utilisation:  \n• Shareholders authorised the board on 26 May 2026 to repurchase up to 84.12 million shares.  \n• Cumulative buybacks under this mandate now total 0.91 million shares, representing 1.08 % of the company’s issued share capital at mandate date.  \n• Approximately 83.21 million shares—98.9 % of the approved limit—remain available for future repurchases.\nPursuant to Hong Kong listing rules, Consun Pharma is restricted from issuing new shares or disposing of treasury shares until 11 July 2026, 30 days after the latest repurchase.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1142391568","isCrawlerRequest":true}